AUG 04, 2022 10:01 AM PDT

Medical Marijuana Research Expansion Act

WRITTEN BY: Helaine Krysik

The U.S. House recently revised and passed an updated version of a cannabis research bill, which could significantly affect how the science community works with the plant. The Medical Marijuana Research Expansion Act, if approved by the Senate and the President, would be a quantum leap forward in terms of weed research.

The Act would jumpstart cannabis science research, as well as the related drug development, as one of the biggest changes would instituting deadlines in which regulatory agencies can approve scientists’ applications for clinical trials.

The legislation would also require that the U.S. Attorney General actively solicit applications from the science community for the research and trials. It would also stipulate that a timeline be instituted for the application process.

Licensed scientists would now have access to cannabis flower and other products that they have long been denied for research, as long as the flower and products are legally produced according to their respective state guidelines. This would be a considerable catalyst in weed science on the university level in legal cannabis states.

The bill, if passed, would also require agencies like the U.S. Department of Health & Human Services to report on the therapeutic benefits of CBD and THC in serious health conditions.

The FDA would be permitted to analyze CBD and medical THC containing products, and publish conclusions available to the public so that potential buyers can make more informed purchasing decisions.

The biggest takeaway from this pending legislation, if passed, is not only would it apply deadlines to approving agencies, but it would do more to raise the profile of cannabis research overall.

The Act would help ease and eventually eliminate the bias that has long been applied to studies in weed science. This lack of bias would help to further legitimize the plant’s image overall, and spawn all sorts of new business opportunities, many of which would be in areas that no one can yet predict.

 

Sources: Congress.gov, hhs.gov, MJBizDaily

About the Author
Marketing
Helaine is a cannabis industry writer and marketing consultant. She has been active in the Illinois cannabis industry since 2020, and writes for a variety of national publications.
You May Also Like
FEB 03, 2022
Cannabis Sciences
A Standard THC Unit: Standardizing Dosage in Cannabis Industry & Research
FEB 03, 2022
A Standard THC Unit: Standardizing Dosage in Cannabis Industry & Research
A primary limitation of cannabis research thus far has been the inconsistent quantification of exposure to the plant&rsq ...
FEB 24, 2022
Cannabis Sciences
Study Reveals Cannabis and Tobacco Affect the Lungs Differently
FEB 24, 2022
Study Reveals Cannabis and Tobacco Affect the Lungs Differently
Scientists recently discovered differences in how long-term consumption of cannabis and tobacco affect the lungs. A stud ...
JUN 02, 2022
Cannabis Sciences
Choosing the right soil for cannabis grows
JUN 02, 2022
Choosing the right soil for cannabis grows
Soil plays a huge role in growing high quality cannabis. Here's what to look for.
JUN 09, 2022
Cannabis Sciences
Do you know what you're vaping?
JUN 09, 2022
Do you know what you're vaping?
Do you know what vaping is, and what's in your vape? Here's what to know.
JUN 10, 2022
Cannabis Sciences
Funding For Research on Weed's Role in Cancer Treatments
JUN 10, 2022
Funding For Research on Weed's Role in Cancer Treatments
The government is now starting to fund cannabis's role in cancer treatments. Here's how it's developing.
JUL 08, 2022
Cannabis Sciences
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
JUL 08, 2022
$2 Million in NIH Awards go to Study Adolescent Cannabis Use
The NIH's National Institute on Drug Abuse awarded more than $2 million to Indiana University’s Gill Center fo ...
Loading Comments...